Lung cancer remains one of the leading causes of cancer-related deaths globally. Early detection through effective screening is vital in reducing mortality rates, as it allows for timely intervention and treatment. The lung cancer screening market has seen significant growth,…

The lung cancer screening market has experienced significant growth, driven by the increasing number of lung cancer cases worldwide. Valued at USD 2.5 billion in 2023, this market is projected to grow at a compound annual growth rate (CAGR) of…